Pivmecillinam, also known as amdinocillin pivoxil, is an orally active, extended-spectrum antibiotic belonging to the penicillin family. Sold under various brand names such as Selexid and Pivya, among others, this antibiotic is primarily a prodrug of mecillinam and is technically the pivaloyloxymethyl ester of mecillinam. Pivmecillinam offers a broad spectrum of antimicrobial activity against a wide range of bacteria, including both gram-positive and gram-negative strains. The antibiotic has a unique mechanism of action that inhibits bacterial cell wall synthesis, thereby triggering the death of the bacteria.

Parent: Pivmecillinam
Parent: Pivmecillinam
The impurity profile of Pivmecillinam is tightly regulated and carefully monitored to reduce the risk of toxicity and side effects. The impurities are related compounds or degradation products that can be formed during the synthesis, storage, or handling of Pivmecillinam. These impurities may include process-related impurities, such as unreacted raw materials, by-products, and intermediates derived from the manufacturing process. Recognition and quantification of these impurities are critical to ensure both the safety and efficacy of the drug. However, the allowed maximum limit for any individual impurity in Pivmecillinam is below 0.1% as per the regulatory guidelines.
Pivmecillinam is primarily used for treating urinary tract infections (UTIs). It works by killing or stopping the growth of the bacteria causing the infection.
Typically, a course of pivmecillinam for a urinary tract infection lasts for about 3 to 7 days, but the exact duration can depend on the specific patient’s condition, including the severity of the infection and the patient’s overall health status.
Pivmecillinam is a member of the penicillin family of antibiotics. However, its chemical structure and properties are different from penicillin, so clinically, it is not considered the same.
Both Pivmecillinam and Nitrofurantoin are effective antibiotics used to treat urinary tract infections. The decision to use one over the other largely depends on the specific bacteria causing the infection, the patient’s personal medical history, and the potential side effects of each medication.